A compound with the SMILES C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)COC(=O)C(F)(F)F)nn3)CC2)nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)CC(C)C)nn3)CC2)n1.Cl has a hERG inhibition at a concentration of 10uM of 28.481%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)COC(=O)C(F)(F)F)nn3)CC2)nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)CC(C)C)nn3)CC2)n1.Cl
C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)COC(=O)C(F)(F)F)nn3)CC2)nc(N2CCN(C(=O)C([C@@H](C)CC)n3cc(C(N)CC(C)C)nn3)CC2)n1.Cl
[2-amino-2-[1-[(3S)-1-[4-[4-[4-[(3S)-2-[4-(1-amino-3-methylbutyl)triazol-1-yl]-3-methylpentanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-3-methyl-1-oxopentan-2-yl]triazol-4-yl]ethyl] 2,2,2-trifluoroacetate;hydrochloride